Monogram Biosciences to Present at the JMP Securities Seventh Annual Research Conference

Monogram Biosciences to Present at the JMP Securities Seventh Annual Research
Conference

SOUTH SAN FRANCISCO, Calif., April 14 /PRNewswire-FirstCall/ -- Monogram
Biosciences, Inc. (Nasdaq: MGRM) announced today that William D. Young, CEO
and Chairman, is scheduled to present a corporate overview at the Seventh
Annual JMP Securities Research Conference on Wednesday, May 21, 2008 at 5:00
p.m. Eastern Time (2:00 p.m. Pacific Time) at the Ritz-Carlton Hotel in San
Francisco, California.
To access the live audio broadcast or the subsequent archived recording,
log on to www.monogrambio.com and go to the investor relations section
("Investors/Media" tab) and click on the "Events & Webcasts" link provided on
the sidebar menu on the page.
About Monogram Biosciences, Inc.
Monogram is advancing individualized medicine by discovering, developing
and marketing innovative products to guide and improve treatment of serious
infectious diseases and cancer. The Company's products are designed to help
doctors optimize treatment regimens for their patients that lead to better
outcomes and reduced costs. The Company's technology is also being used by
numerous biopharmaceutical companies to develop new and improved antiviral
therapeutics and vaccines as well as targeted cancer therapeutics. More
information about the Company and its technology can be found on its web site
at www.monogrambio.com.
contacts: Alfred G. Merriweather Jeremiah Hall
Chief Financial Officer Feinstein Kean Healthcare
Tel: 650 624-4576 Tel: 415 677-2700
amerriweather@monogrambio.com jeremiah.hall@fkhealth.com

SOURCE Monogram Biosciences, Inc.

Alfred G. Merriweather, Chief Financial Officer of Monogram Biosciences, Inc.,
+1-650-624-4576, amerriweather@monogrambio.com; Jeremiah Hall, Feinstein Kean
Healthcare, +1-415-677-2700, jeremiah.hall@fkhealth.com